|drug3953||nasopharyngeal Covid 19 RT-PCR Wiki||1.00|
|D006528||Carcinoma, Hepatocellular NIH||1.00|
There is one clinical trial.
The purpose of this trial is to compare 2 types of nasonasopharyngeal swabs (a new design to a conventional nylon-flocked nasopharyngeal swab) for effectiveness.
Description: amount of SARS-CoV2 virus (COVID-19) collected measured in CT (thermal cycles).Measure: Amount of SARS-CoV2 virus (COVID-19) collected Time: Baseline
Description: Calculate approximate sensitivity and specificity of the CanSwab to the Flocked swab control.Measure: Clinical concordance rate Time: Baseline
Description: Patient description of comfort level between the 2 swabs experience measured by "Worse", "Identical" or "Better"Measure: Patient comfort Time: Baseline
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports